scholarly journals From Bad to Worse: The Relationship Between Opioid Use and Inflammatory Bowel Disease

2020 ◽  
Vol 14 (9) ◽  
pp. 1188-1189
Author(s):  
Keith Sultan ◽  
Arun Swaminath
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Opioid Use ◽  
Inflammatory Bowel ◽  
The Relationship

One-year risk of opioid use disorder after index hospitalization for inflammatory bowel disease

2020 ◽  
Vol 35 (11) ◽  
pp. 2081-2087
Author(s):  
Mishal Reja ◽  
Nitya Hajela ◽  
Michael Makar ◽  
Daniel Marino ◽  
Abhishek Bhurwal ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Opioid Use Disorder ◽  
Index Hospitalization ◽  
Opioid Use ◽  
Inflammatory Bowel ◽  
One Year

scholarly journals Distinct Cutoff Values of Adalimumab Trough Levels Are Associated With Different Therapeutic Outcomes in Patients With Inflammatory Bowel Disease

2019 ◽  
Vol 1 (3) ◽  
Author(s):  
Sang Hyoung Park ◽  
Badr Al-Bawardy ◽  
Satimai Aniwan ◽  
Sunanda V Kane ◽  
Nayantara Coelho-Prabhu ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Disease Activity ◽  
Bowel Disease ◽  
Cutoff Value ◽  
Reactive Protein ◽  
Therapeutic Outcomes ◽  
Inflammatory Bowel ◽  
Relationship Of ◽  
The Relationship ◽  
Trough Levels

Abstract Background and Aims We aimed to evaluate the relationship of serum adalimumab trough levels (ATL) with disease activity of inflammatory bowel disease (IBD) patients in a large, well-characterized referral center-based cohort. Methods We compared serum ATL between those with clinical, biochemical, or endoscopic/radiologic disease activity and those without. Results A total of 236 patients with IBD were included. Higher cutoff levels were associated with endoscopic and/or radiologic responses (cutoff value: 5.3 mcg/mL, P = 0.003) compared with improvement in C-reactive protein (cutoff value: 4.3 mcg/mL, P = 0.031). Conclusions Higher cutoff ATL was associated with endoscopic and/or radiologic response.

Sign in / Sign up

Export Citation Format

Share Document